Perspectives is committed to providing timely and relevant information on postoperative recovery strategies. Our articles focus on the continuum of care from operating room to recovery room, ward, or home. Perspectives strives to provide pertinent, pragmatic information, continuing education, and gudelines to maximize nurses' ability to enhance patient outcomes and minimize secondary (iatrogenic) problems. Our articles are authored by nurses, who have in depth knowledge and experience in a broad range of clinical specialties, and are reviewed by our advisory board. We welcome opinions and suggestions from our readers. In each issue, we will provide our readers with an opportunity to earn continuing education credits.

Advisory Board

Lois Dixon, MSN, RN
Clinical Nurse Educator,
Genesis Medical Center, Davenport, IA

Jan Foster, RN, PhD, MSN, CCRN
Asst. Professor for Adult Acute and
Critical Care Nursing
Houston Baptist University, TX

Mikel Gray, PhD, CUNP, CCCN, FAAN
Nurse Practitioner and Professor of Urology,
School of Nursing, University of Virginia,
Charlottesville, VA

Tracey Hotta, RN, BScN, CPSN
Past-president, American Society of
Plastic Surgery Nurses
Toronto, Ontario, Canada

Tim Op't Holt EdD, RRT, AEC, FAARC
Professor, Dept. of Respiratory care and Cardiopulmonary Sciences
University of South Alabama
Moblile, AL

Victoria-Base Smith, PhD(c), MSN, CRNA, CCRN
Clinical Assistant Professor,
Nurse Anesthesia,
University of Cincinnati, OH

Current Issue


Ventilator-Associated Pneumonia and Tracheostomy
Charles G. Durbin Jr, MD, FCCM, FAARC
Ventilator-associated pneumonia (VAP) is defined as a lower respiratory tract infection occurring at least 2 days after beginning mechanical ventilation. While VAP is named for its association with mechanical ventilation, it is believed to be caused by oral or nasotracheal intubation and only coincidently related to mechanical ventilation. VAP is considered to be clinically significant with an estimated associated mortality rate of 24% to 50%. In addition to increasing the likelihood of death in the ICU or hospital, VAP survivors have a reduced life expectancy after hospital discharge. For example, a study by Ranes revealed that 25.9% of survivors of VAP were dead 1 year later, and 44.7% survived no more than 5 years.

This issue is accredited for both Nurses and
Respiratory Therapists

Ventilator-Associated Pneumonia and Tracheostomy
Charles G. Durbin Jr, MD, FCCM, FAARC
Ventilator-associated pneumonia (VAP) is defined as a lower respiratory tract infection occurring at least 2 days after beginning mechanical ventilation. While VAP is named for its association with mechanical ventilation, it is believed to be caused by oral or nasotracheal intubation and only coincidently related to mechanical ventilation. VAP is considered to be clinically significant with an estimated associated mortality rate of 24% to 50%. In addition to increasing the likelihood of death in the ICU or hospital, VAP survivors have a reduced life expectancy after hospital discharge. For example, a study by Ranes revealed that 25.9% of survivors of VAP were dead 1 year later, and 44.7% survived no more than 5 years.

This issue is accredited for both Nurses and
Respiratory Therapists

Perspectives is published quarterly by Saxe Healthcare Communications. Please direct your correspondence to:

Saxe Healthcare Communications
P.O. Box 1282
Burlington, VT 05402
info@saxecommunications.com
Fax: (802) 872-7558

Perspectives is sponsered by Dale Medical

All issues of Perspectives can
be viewed on an iPad.
Please click here for instructions

 

 

 

 

 

 

 
\